Table 2.
Relation to peak VO2 | Total study population (n = 100) |
Patients with HFpEF (n = 37) |
||||||
---|---|---|---|---|---|---|---|---|
Univariate correlation |
Multivariate regression |
Univariate correlation |
Multivariate regression |
|||||
R | P-value | β (95% CI) | P-value | R | P-value | β (95% CI) | P-value | |
Age, per 5 years | 0.13 | 0.20 | −0.37 (−0.85 to 0.12) | 0.13 | −0.01 | 0.99 | −1.07 (−2.07 to −0.07) | 0.04 |
NYHA class | −0.77 | <0.001 | −0.65 | <0.001 | ||||
NT-proBNP, per 10 pmol/L | −0.35 | 0.002 | −0.02 (−0.04 to 0.01) | 0.25 | −0.47 | 0.02 | ||
LV EDD index | −0.43 | <0.001 | 0.08 (−0.16 to 0.33) | 0.50 | 0.12 | 0.48 | ||
LV EF | 0.62 | <0.001 | −0.01 (−0.13 to 0.11) | 0.87 | 0.08 | 0.62 | ||
LV GLS | −0.63 | <0.001 | −0.42 (−0.79 to −0.04) | 0.03 | −0.50 | 0.002 | −0.80 (−1.49 to −0.11) | 0.02 |
TAPSE | 0.27 | 0.008 | 0.39 (−1.18 to 1.96) | 0.62 | 0.49 | 0.003 | ||
RV S′ | 0.33 | 0.001 | 0.02 (−0.34 to 0.38) | 0.92 | 0.35 | 0.04 | 0.54 (−0.10 to 1.19) | 0.09 |
Peak PASP | −0.55 | <0.001 | −0.15 (−0.28 to −0.02) | 0.02 | −0.49 | 0.002 | −0.35 (−0.68 to −0.02) | 0.04 |
RV FAC | 0.54 | <0.001 | 0.35 | 0.03 | 0.08 (−0.11 to 0.28) | 0.38 | ||
RV strain | −0.50 | <0.001 | −0.34 | 0.05 | ||||
E | −0.28 | 0.04 | −0.39 | 0.02 | ||||
E deceleration time | 0.48 | <0.001 | 0.34 | 0.04 | ||||
E/A | −0.43 | <0.001 | −0.26 | 0.13 | ||||
e′ | 0.46 | <0.001 | 0.20 | 0.24 | ||||
E/e′ | −0.41 | <0.001 | 0.06 (−0.05 to 0.18) | 0.28 | −0.43 | 0.008 | 0.12 (−0.44 to 0.69) | 0.66 |
Left atrial area | −0.40 | <0.001 | −0.28 | 0.09 | ||||
Left atrial volume index | −0.41 | <0.001 | −0.03 (−0.08 to 0.02) | 0.16 | −0.28 | 0.09 |
A, late diastolic filling velocity; β, beta regression coefficient; CI, confidence interval; E, peak early diastolic filling velocity; e′, early diastolic mitral annular velocity(septal); EDD, end diastolic diameter; EF, ejection fraction; FAC, fractional area change; GLS, global longitudinal strain; HFpEF, heart failure with preserved ejection fraction; LV, left ventricular; NYHA, New York Heart Association; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PASP, pulmonary arterial systolic pressure; R, Pearson coefficient; RV, right ventricular; S′, tricuspid lateral annular systolic velocity; TAPSE, tricuspid annular plane systolic excursion; VO2, oxygen uptake.